| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Patel Purav serves as a Director at RVPH. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $204K at current prices.
The biggest single holding is RVPH (~$204K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 3,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2022 | RVPH Reviva Pharmaceuticals Holdings, Inc. | Director | Buy | 3,000 | $4.69 | $14,070.00 | +7.4% | -1.5% | -13.9% |